What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
Patients with pre-existing gastrointestinal conditions should maintain closer monitoring
Some patients may experience mild nausea, injection site soreness, or temporary body odor changes
Experience the power of PatchMD's vitamin patches and supplements, all with free shipping
[DOI] [PubMed] [Google Scholar] 48.Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., Kikugawa K
Autophagy in kidney disease: advances and therapeutic potential
